LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.27 | 770.25 | 6702 | 7058 | 0.9494 | 0.9678 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 54.49 | 770.25 | 7499 | 7555 | 0.9925 | 0.9955 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 54.49 | 770.25 | 7127 | 7555 | 0.9433 | 0.9649 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 56.71 | 770.25 | 7918 | 8001 | 0.9896 | 0.9938 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 56.71 | 770.25 | 7342 | 8001 | 0.9176 | 0.9497 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.94 | 770.25 | 8540 | 8444 | 1.0113 | 1.0065 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.94 | 770.25 | 7771 | 8444 | 0.9203 | 0.9525 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.16 | 770.25 | 8970 | 8892 | 1.0088 | 1.0050 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.16 | 770.25 | 8070 | 8892 | 0.9076 | 0.9458 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.39 | 770.25 | 9423 | 9326 | 1.0104 | 1.0058 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.39 | 770.25 | 8407 | 9326 | 0.9015 | 0.9432 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.61 | 770.25 | 9808 | 9736 | 1.0074 | 1.0040 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.61 | 770.25 | 8691 | 9736 | 0.8927 | 0.9389 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.83 | 770.25 | 10132 | 10078 | 1.0053 | 1.0029 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.83 | 770.25 | 8837 | 10078 | 0.8768 | 0.9304 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.05 | 770.25 | 10548 | 10413 | 1.0129 | 1.0068 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.05 | 770.25 | 8998 | 10413 | 0.8641 | 0.9237 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.27 | 770.25 | 10845 | 10730 | 1.0106 | 1.0056 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.27 | 770.25 | 9066 | 10730 | 0.8449 | 0.9132 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 74.50 | 770.25 | 11178 | 10991 | 1.0170 | 1.0088 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 74.50 | 770.25 | 9237 | 10991 | 0.8404 | 0.9113 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.75 | 770.25 | 11540 | 11262 | 1.0246 | 1.0126 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.75 | 770.25 | 9460 | 11262 | 0.8399 | 0.9119 | MN20160304_L02 | I04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.98 | 770.25 | 11891 | 11518 | 1.0324 | 1.0164 | MN20160304_L02 | D22 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.98 | 770.25 | 9585 | 11518 | 0.8322 | 0.9080 | MN20160304_L02 | I04 |